A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan

Yi-Heng Li, Jaw Wen Chen, Tsung Hsien Lin, Yu Chen Wang, Chau Chung Wu, Hung I. Yeh, Chin Chou Huang, Kuan Cheng Chang, Cho Kai Wu, Po-Wei Chen, Chen-Wei Huang, Zhih Cherng Chen, Wei Ting Chang, Wei Chun Huang, Chih Yuan Wang, Mei Yueh Lee, A. Ching Chao, Wei Ren Fu, Li Kai Tsai, Sung Chun Tang & 5 others Hsin Lung Chan, Yi-Ching Yang, Yen Wen Wu, Juey Jen Hwang, Jiunn Lee Lin

Research output: Contribution to journalReview article

Abstract

Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan)to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations.

Original languageEnglish
JournalJournal of the Formosan Medical Association
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Taiwan
Cardiovascular Diseases
Cerebrovascular Disorders
Peripheral Arterial Disease
Hypercholesterolemia
Cardiology
Blood Glucose
Coronary Artery Disease
Atherosclerosis
Diabetes Mellitus
Cholesterol
Guidelines
Blood Pressure
Hypertension
Morbidity
Delivery of Health Care
Lipids
Mortality

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Li, Yi-Heng ; Chen, Jaw Wen ; Lin, Tsung Hsien ; Wang, Yu Chen ; Wu, Chau Chung ; Yeh, Hung I. ; Huang, Chin Chou ; Chang, Kuan Cheng ; Wu, Cho Kai ; Chen, Po-Wei ; Huang, Chen-Wei ; Chen, Zhih Cherng ; Chang, Wei Ting ; Huang, Wei Chun ; Wang, Chih Yuan ; Lee, Mei Yueh ; Chao, A. Ching ; Fu, Wei Ren ; Tsai, Li Kai ; Tang, Sung Chun ; Chan, Hsin Lung ; Yang, Yi-Ching ; Wu, Yen Wen ; Hwang, Juey Jen ; Lin, Jiunn Lee. / A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan. In: Journal of the Formosan Medical Association. 2019.
@article{eae582b590ba43abad15898f3f309857,
title = "A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan",
abstract = "Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan)to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations.",
author = "Yi-Heng Li and Chen, {Jaw Wen} and Lin, {Tsung Hsien} and Wang, {Yu Chen} and Wu, {Chau Chung} and Yeh, {Hung I.} and Huang, {Chin Chou} and Chang, {Kuan Cheng} and Wu, {Cho Kai} and Po-Wei Chen and Chen-Wei Huang and Chen, {Zhih Cherng} and Chang, {Wei Ting} and Huang, {Wei Chun} and Wang, {Chih Yuan} and Lee, {Mei Yueh} and Chao, {A. Ching} and Fu, {Wei Ren} and Tsai, {Li Kai} and Tang, {Sung Chun} and Chan, {Hsin Lung} and Yi-Ching Yang and Wu, {Yen Wen} and Hwang, {Juey Jen} and Lin, {Jiunn Lee}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jfma.2019.04.007",
language = "English",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Excerpta Medica Asia Ltd.",

}

Li, Y-H, Chen, JW, Lin, TH, Wang, YC, Wu, CC, Yeh, HI, Huang, CC, Chang, KC, Wu, CK, Chen, P-W, Huang, C-W, Chen, ZC, Chang, WT, Huang, WC, Wang, CY, Lee, MY, Chao, AC, Fu, WR, Tsai, LK, Tang, SC, Chan, HL, Yang, Y-C, Wu, YW, Hwang, JJ & Lin, JL 2019, 'A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan', Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2019.04.007

A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan. / Li, Yi-Heng; Chen, Jaw Wen; Lin, Tsung Hsien; Wang, Yu Chen; Wu, Chau Chung; Yeh, Hung I.; Huang, Chin Chou; Chang, Kuan Cheng; Wu, Cho Kai; Chen, Po-Wei; Huang, Chen-Wei; Chen, Zhih Cherng; Chang, Wei Ting; Huang, Wei Chun; Wang, Chih Yuan; Lee, Mei Yueh; Chao, A. Ching; Fu, Wei Ren; Tsai, Li Kai; Tang, Sung Chun; Chan, Hsin Lung; Yang, Yi-Ching; Wu, Yen Wen; Hwang, Juey Jen; Lin, Jiunn Lee.

In: Journal of the Formosan Medical Association, 01.01.2019.

Research output: Contribution to journalReview article

TY - JOUR

T1 - A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan

AU - Li, Yi-Heng

AU - Chen, Jaw Wen

AU - Lin, Tsung Hsien

AU - Wang, Yu Chen

AU - Wu, Chau Chung

AU - Yeh, Hung I.

AU - Huang, Chin Chou

AU - Chang, Kuan Cheng

AU - Wu, Cho Kai

AU - Chen, Po-Wei

AU - Huang, Chen-Wei

AU - Chen, Zhih Cherng

AU - Chang, Wei Ting

AU - Huang, Wei Chun

AU - Wang, Chih Yuan

AU - Lee, Mei Yueh

AU - Chao, A. Ching

AU - Fu, Wei Ren

AU - Tsai, Li Kai

AU - Tang, Sung Chun

AU - Chan, Hsin Lung

AU - Yang, Yi-Ching

AU - Wu, Yen Wen

AU - Hwang, Juey Jen

AU - Lin, Jiunn Lee

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan)to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations.

AB - Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan)to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations.

UR - http://www.scopus.com/inward/record.url?scp=85065676780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065676780&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2019.04.007

DO - 10.1016/j.jfma.2019.04.007

M3 - Review article

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

ER -